Fortress Biotech
FBIO
$1.89
Share price
-4.55%
Change (1 day)
-14.09%
Change (1 year)
Categories
Revenue for Fortress Biotech (FBIO)
Revenue in 2025 (TTM): $57.78 Million USD
According to Fortress Biotech
's latest financial reports the company's current revenue (TTM 
) is $57.78 Million USD. In 2024 the company made a revenue of $57.67 Million USD a decrease over the revenue in the year 2023 that were of $84.51 Million USD. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Fortress Biotech from 2011 to 2025
Annual revenue
| Year | Revenue | Change |
|---|---|---|
| 2025 (TTM) | $57.78 M | 0.19% |
| 2024 | $57.67 M | -31.76% |
| 2023 | $84.51 M | 11.58% |
| 2022 | $75.74 M | 10.11% |
| 2021 | $68.79 M | 50.86% |
| 2020 | $45.59 M | 24.49% |
| 2019 | $36.62 M | -126.51% |
| 2018 | -$0.14 Billion | -173.66% |
| 2017 | $0.18 B | 1038.25% |
| 2016 | $16.48 M | 1809.62% |
| 2015 | $0.86 M | |
| 2014 | N/A | |
| 2013 | N/A | |
| 2012 | N/A | |
| 2011 | N/A |
Revenue for similar companies or competitors
| Company | Revenue | Revenue differencediff. | Country |
|---|---|---|---|
 Advaxis ADXS | $0.11 M | -99.80% | 🇺🇸 USA |
 Veracyte VCYT | $0.46 B | 701.94% | 🇺🇸 USA |
 Dicerna Pharmaceuticals DRNA | $0.19 B | 233.74% | 🇺🇸 USA |
 Dynavax Technologies
DVAX | $0.29 B | 409.87% | 🇺🇸 USA |